학술논문

Long-term efficacy and safety of canakinumab in the treatment of systemic juvenile idiopathic arthritis in Japanese patients: Results from an open-label Phase III study
Document Type
Journal
Source
MODERN RHEUMATOLOGY; NOV 18 2022, 9p.
Subject
Language
English
ISSN
14397609